Candel Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Candel Therapeutics (CADL) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Candel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Candel Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Candel Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $136k | 27k | 5.10 |
| 2025-06-30 | $109k | 22k | 5.06 |
| 2025-03-31 | $148k | 26k | 5.65 |
| 2024-12-31 | $274k | 32k | 8.68 |
| 2024-09-30 | $3.7k | 533 | 6.93 |
| 2024-06-30 | $422 | 68 | 6.21 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft